15 October 2018: “AFTINET welcome the pledges for progressive changes to future trade policy in shadow Trade Minister Jason Clare’s Bill announced today, as the TPP-11 implementing legislation is being debated by the Senate. However we remain opposed to theTPP-11 because it restricts the right of future governments to regulate in the public interest.
Media Release - September 18, 2018
“We are deeply disappointed that the Labor majority report of the Senate Standing Committee on the TPP-11 has strongly criticized many aspects of the deal and recommended changes by a future government, but has nevertheless endorsed its implementation,” AFTINET Convener Dr Patricia Ranald said today.
September 11, 2018: “By deciding to endorse the TPP-11 implementing legislation, the majority in the ALP Caucus has made a decision contrary to their own policies, and has deeply disappointed many community organisations,” AFTINET Convener Dr Patricia Ranald said today.
Media Release, August 22, 2018
“The report of the Government-dominated Joint Standing Committee on Treaties has predictably recommended the endorsement of the TPP-11 implementing legislation,” AFTINET Convener Dr Patricia Ranald said today.
“However, ALP committee members made the following critical comments: (pp 85-95)
Media Release: July 30, 2018: “AFTINET will present evidence today to a Senate inquiry that the TPP-11 increases corporate rights at the expense of people’s rights and the environment and should not be implemented,” AFTINET Convener Dr Patricia Ranald said today.
Media Release, May 14, 2018: “US President Donald Trump’s policy to end “freeloading” and force trading partners to increase prices they pay for US pharmaceutical exports is a direct threat to Australia’s policy of ensuring affordable medicines through our Pharmaceutical Benefits Scheme,” AFTINET Convener Dr Patricia Ranald said today.
“This policy results from the US pharmaceutical companies absurd and unproven argument that if other governments abandon their affordable medicine policies and agree to higher prices, the companies would then lower their prices in the US. Both Canada and New Zealand have strongly rejected this push. There has so far been no reported response from the Turnbull government. We call on the government to reject this policy,” said Dr Ranald.
Media Release, April 13: "US President Trump’s announcement that he will renegotiate what is now the TPP-11 exposes the dodgy nature of the deal. The remaining 11 countries reached agreement on the basis that bad provisions sponsored by the US are identified as unacceptable but are only suspended and remain in the deal, and could be reactivated if the US re-joined,” AFTINET Convener Dr Patricia Ranald said today.
Media release April 4, 2018: AFTINET Convener Dr Patricia Ranald today called on the government not to cut short parliamentary inquiries which are intended to scrutinise the revised TPP-11 (renamed the Progressive Comprehensive TPP) before Parliament votes on the implementing legislation.
Media release, 9 March 2018: Dr Patricia Ranald, Convener of the Australian Fair Trade and Investment Network called today for a Senate Inquiry to assess whether the rebadged Comprehensive Progressive TPP is in the public interest, before Parliament considers the implementing legislation.